Chen, Liqiao
Xu, Jieli
Li, Jialin
Ji, Ke
Zhang, Ji
Wu, Xiaojiang
Zhou, Kai
Tang, Jiatian
Wu, Yan
Wang, Anqiang
Bu, Zhaode
Funding for this research was provided by:
National Key Research and Development Program of China (No.2023YFF1204700, branch No.2023YFF1204702)
Article History
Received: 20 October 2025
Accepted: 5 December 2025
First Online: 10 December 2025
Declarations
:
: This study of human data was performed according to the Declaration of Helsinki and Good Clinical Practice. The protocol of this research and the license for usage of clinical data were given by the Ethics Committee of Peking University Cancer Hospital and Institute (code PY202329). All patients were informed and signed the informed consent form.
: Not applicable.
: The authors declare no competing interests.